Literature DB >> 29891907

Cumulative mean arterial pressure and risks of adverse cardiac and cerebrovascular events: a prospective cohort study of 53,813 adults.

Xiao Cui1, Quanhui Zhao2,3, Junxing Yu2,3, Ruiying Zhang2,3, Wei Li2,3, Lu Song2,3, Chunhui Li2,3, Hualing Zhao2,3, Aiping Wu4, Shouling Wu5, Jun Cai6.   

Abstract

The association between cumulative mean arterial blood pressure (MAP) and risks of adverse cardiac and cerebrovascular events (CCVEs) has not been characterized. This prospective cohort study included 53,813 participants, free of prior myocardial infarction or stroke in or before 2010 (baseline) from a community-based cohort including 101,510 participants. Cumulative MAP was defined as the summed average MAP for each pair of consecutive examinations multiplied by the time interval with the data from previous surveys (2006- 2007, 2008 to 2009, 2010-2011). Incident adverse CCVEs were ascertained by both the information collection in biennial follow-up surveys (2012-2013, 2014-2015) and surveying each year's discharge lists from local hospitals and death certificates from state vital statistics offices by three experienced physicians blinded to the study design. The study population were stratified into quartiles based on cumulative MAP (<354.62 mmHg, n = 13,454; 354.62 to 392.82 mmHg, n = 13,452; 392.82 to 438.04 mmHg, n = 13 453; ≥ 438.04 mmHg, n = 13,454). We documented 1055 incident adverse CCVEs, including 271 myocardial infarction and 794 stroke (10 comorbid with myocardial infarction), which consisted of 673 ischemic stroke and 134 hemorrhagic stroke (13 comorbid with ischemic stroke). The incidence of adverse CCVEs increased with the increase of cumulative MAP with significant difference (p < 0.001). Cox proportional hazards regression models revealed the elevated cumulative MAP as an independent risk factor for adverse CCVEs, especially hemorrhagic stroke, after adjusting potential confounders. A J-shaped relationship between cumulative MAP and hemorrhagic stroke was also observed.

Entities:  

Mesh:

Year:  2018        PMID: 29891907     DOI: 10.1038/s41371-018-0075-9

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  23 in total

1.  High pulse pressure and low mean arterial pressure: two predictors of death after a myocardial infarction.

Authors:  Fausto Avanzini; Claudio Alli; Alessandro Boccanelli; Carmine Chieffo; Maria G Franzosi; Enrico Geraci; Aldo P Maggioni; Rosa M Marfisi; Gian L Nicolosi; Carlo Schweiger; Luigi Tavazzi; Gianni Tognoni; Franco Valagussa; Roberto Marchioli
Journal:  J Hypertens       Date:  2006-12       Impact factor: 4.844

2.  Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease.

Authors:  Ann Marie Navar-Boggan; Eric D Peterson; Ralph B D'Agostino; Benjamin Neely; Allan D Sniderman; Michael J Pencina
Journal:  Circulation       Date:  2015-01-26       Impact factor: 29.690

3.  Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32 years.

Authors:  Timo E Strandberg; Veikko V Salomaa; Hannu T Vanhanen; Kaisu Pitkälä; Tatu A Miettinen
Journal:  J Hypertens       Date:  2002-03       Impact factor: 4.844

4.  Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural areas of China.

Authors:  Liqiang Zheng; Zhaoqing Sun; Jue Li; Rui Zhang; Xingang Zhang; Shuangshuang Liu; Jiajin Li; Changlu Xu; Dayi Hu; Yingxian Sun
Journal:  Stroke       Date:  2008-05-01       Impact factor: 7.914

5.  Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke.

Authors:  Qian Zhang; Yong Zhou; Xiang Gao; Chunxue Wang; Shufeng Zhang; Anxin Wang; Na Li; Liheng Bian; Jianwei Wu; Qian Jia; Shouling Wu; Xingquan Zhao
Journal:  Stroke       Date:  2013-07-18       Impact factor: 7.914

6.  Low diastolic blood pressure and mortality in a population-based cohort of 16913 hypertensive patients in North Karelia, Finland.

Authors:  J Tuomilehto; O P Ryynänen; A Koistinen; D Rastenyte; A Nissinen; P Puska
Journal:  J Hypertens       Date:  1998-09       Impact factor: 4.844

7.  Age- and gender-specific associations between sleep duration and incident hypertension in a Chinese population: the Kailuan study.

Authors:  Q Song; X Liu; X Wang; S Wu
Journal:  J Hum Hypertens       Date:  2016-01-14       Impact factor: 3.012

8.  Stroke--1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders.

Authors: 
Journal:  Stroke       Date:  1989-10       Impact factor: 7.914

9.  Blood Pressure Trajectories and the Risk of Intracerebral Hemorrhage and Cerebral Infarction: A Prospective Study.

Authors:  Weijuan Li; Cheng Jin; Anand Vaidya; Yuntao Wu; Kathryn Rexrode; Xiaoming Zheng; Mahmut E Gurol; Chaoran Ma; Shouling Wu; Xiang Gao
Journal:  Hypertension       Date:  2017-07-17       Impact factor: 10.190

10.  Blood pressure and in-hospital outcomes in patients presenting with ischaemic stroke.

Authors:  Sripal Bangalore; Lee Schwamm; Eric E Smith; Anne S Hellkamp; Robert E Suter; Ying Xian; Phillip J Schulte; Gregg C Fonarow; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2017-10-01       Impact factor: 29.983

View more
  2 in total

1.  The Role of Cumulative Mean Arterial Pressure Levels in First Stroke Events Among Adults with Hypertension: A 10-Year Prospective Cohort Study.

Authors:  Dan Wang; Jiaqi Wang; Jiali Liu; Yu Qin; Peian Lou; Yongqing Zhang; Yuqing Zhang; Quanyong Xiang
Journal:  Clin Epidemiol       Date:  2022-05-04       Impact factor: 5.814

2.  Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events.

Authors:  Yingting Zuo; Deqiang Zheng; Shuohua Chen; Xinghua Yang; Yuxiang Yan; Fen Liu; Xue Tian; Meiping Wang; Xin Su; Jing Wen; Qi Zhai; Yibo Zhang; Herbert Y Gaisano; Shouling Wu; Anxin Wang; Yan He
Journal:  Front Cardiovasc Med       Date:  2021-09-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.